Donald Trump Celebrates Drug Price Plunge, But Experts Credit Biden-Era Law

US President Donald Trump showcased a Washington Post report revealing that prescription drug prices had experienced their most significant year-over-year decline in over six decades, claiming this as evidence of his administration's achievements. However, the cited article indicated that independent experts believed a policy enacted during Joe Biden's presidency was likely the primary driver of the price drop.

The White House circulated a photograph of Trump holding the Washington Post headline, "Prescription drug prices record sharpest drop in more than 60 years," across its social media platforms on Saturday. Press secretary Karoline Leavitt also shared the image. Trump presented the story to reporters during a staged photo-op, urging them to record and photograph the moment.

"The headline today is exactly that," he stated, displaying the headline and article excerpt. "Did you see it?" Trump then read the headline aloud, displaying the page once more before thanking journalists for their coverage. The Washington Post article, published on Thursday, attributed the sharp decline in drug prices to a policy implemented under the Biden administration.

The Inflation Reduction Act, a key legislative accomplishment of Biden's term, was signed into law in 2022 and mandates Medicare to negotiate prices for certain widely used and costly prescription drugs. The policy's first price reductions began at the start of this year. Experts, however, questioned Trump's assertion, suggesting that the Inflation Reduction Act, not his administration's actions, was responsible for the decline in drug prices.

Richard Frank, a Harvard University health economics professor, expressed skepticism about Trump's policies contributing to the price drop, pointing to the Inflation Reduction Act as the more probable cause. Vanderbilt University health policy professor Stacie Dusetzina also attributed the price decline to the Biden-era legislation, noting that only 10 drugs have had their prices negotiated under the Inflation Reduction Act but they are commonly used medications, and their reduced prices likely impacted the overall drug price index.